Immunohistochemically, the TFLCs described in the literature showed variable, although relatively consistent negativity for Pax-2, RCC, CD10, WT-1, P504S, vimentin, CD56 and CD57 [12], and typical (but not obligate) negativity for CK7. This evidence concerns the gene PAX2 and renal cell carcinoma.